We are live on ! Find out more
BIOX icon

Bioceres Crop Solutions

46 hedge funds and large institutions have $112M invested in Bioceres Crop Solutions in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

582% more call options, than puts

Call options by funds: $696K | Put options by funds: $102K

7% more capital invested

Capital invested by funds: $104M → $112M (+$7.78M)

0% more funds holding

Funds holding: 4646 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0.6% less ownership

Funds ownership: 13.95%13.35% (-0.6%)

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

Holders
46
Holders Change
Holders Change %
0%
% of All Funds
0.72%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
7
Increased
9
Reduced
14
Closed
7
Calls
$696K
Puts
$102K
Net Calls
+$594K
Net Calls Change
+$272K
Name Holding Trade Value Shares
Change
Change in
Stake
SP
1
Solel Partners
Massachusetts
$61.2M
AAP
2
Ardsley Advisory Partners
Connecticut
$24.8M -$1.05M -89,947 -5%
APA
3
Arisaig Partners (Asia)
Singapore
$3.55M
Wellington Management Group
4
Wellington Management Group
Massachusetts
$3.08M -$26.4K -2,249 -1%
RA
5
Royce & Associates
New York
$2.4M +$551K +47,000 +35%
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$2M +$1.76M +150,000 New
Federated Hermes
7
Federated Hermes
Pennsylvania
$1.75M
LFCM
8
Long Focus Capital Management
Puerto Rico
$1.59M +$235K +20,000 +20%
Mirae Asset Global Investments
9
Mirae Asset Global Investments
South Korea
$1.24M +$15.3K +1,304 +1%
DC
10
Diametric Capital
Massachusetts
$1.03M -$344K -29,378 -28%
JP Morgan Chase
11
JP Morgan Chase
New York
$949K +$195K +16,671 +31%
ADMI
12
Albert D. Mason Inc
Massachusetts
$910K
OFA
13
Oak Family Advisors
Illinois
$884K -$451K -38,482 -37%
Ameriprise
14
Ameriprise
Minnesota
$767K +$33K +2,814 +5%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$754K
UBS Group
16
UBS Group
Switzerland
$613K +$98.4K +8,396 +22%
Primecap Management
17
Primecap Management
California
$584K -$53.9K -4,600 -10%
Millennium Management
18
Millennium Management
New York
$515K +$452K +38,558 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$457K +$51.1K +4,356 +15%
Stifel Financial
20
Stifel Financial
Missouri
$370K -$40K -3,413 -11%
RJA
21
Raymond James & Associates
Florida
$351K
PCM
22
Prelude Capital Management
New York
$329K -$119K -10,173 -29%
BA
23
Bard Associates
Illinois
$275K -$762 -65 -0.3%
IC
24
IEQ Capital
California
$230K +$202K +17,215 New
SEI Investments
25
SEI Investments
Pennsylvania
$221K +$194K +16,554 New

BIOX Hedge Fund Activity: Q2 2023 in Review

46 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bioceres Crop Solutions (BIOX) for Q2 2023, worth a combined $112M — up 7.5% from $104M a quarter earlier.

Fund positioning in BIOX was balanced in Q2 2023: 7 funds opened new positions, 7 closed out, 9 added to existing stakes and 14 trimmed.

The largest buyer was PNC Financial Services Group, opening a new position worth an estimated $1.76M. The largest seller was Uniplan Investment Counsel, exiting entirely with an estimated $5.48M sold.

  • 46 institutional investors held Bioceres Crop Solutions (BIOX) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $112M of Bioceres Crop Solutions stock for Q2 2023, up 7.5% quarter-over-quarter.
  • 7 funds opened new Bioceres Crop Solutions positions in Q2 2023 and 7 closed out, a net change of 0 holders.
  • The largest Bioceres Crop Solutions buyer in Q2 2023 was PNC Financial Services Group, an estimated $1.76M added.
  • The largest Bioceres Crop Solutions seller in Q2 2023 was Uniplan Investment Counsel, an estimated $5.48M sold.

Based on aggregated 13F filings for Q2 2023.